ClinicalTrials.gg
RecruitingNCT07049484LETOTTUpdated Apr 22, 2026

Clinical and Biomechanical Outcomes of Anterior Cruciate Ligament (ACL) Reconstruction Associated With Lateral Extra-articular Tenodesis (LET)

An observational study in ACL Reconstruction, Tenodesis and ACL Injuries, sponsored by Stefano Zaffagnini. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-04-22.

Sponsored by Stefano Zaffagnini · Observational

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
51
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy — 9 open to participants now, 11 under way, none of them phase 3. Anterior Cruciate Ligament Injuries · Italy.

Planned enrollment
7th of 10
51 · median 68
Started
2026
with 3 others
Observational
10 of 20
7 open now
Primary completion
2028-06
later than 7 of 10 live
Registered
14th of 20
by date
Lead sponsor
5 of 20
Stefano Zaffagnini

Among the 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy, this one is the 7th largest by planned enrollment of the 10 observational ones that give a count, is one of 4 that started in 2026, is one of 10 observational ones, reaches primary completion later than 7 of the 10 other live ones, and was the 14th registered.

Anterior Cruciate Ligament Injuries

626 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.

Browse Anterior Cruciate Ligament Injuries studies →

Open to participants now

9 of the 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Anterior Cruciate Ligament Injuries with a site in Italy, or all of them as a file.
02

Study summary

The anterior cruciate ligament (ACL) is one of the main stabilizers of the knee joint, and its injury is among the most common soft tissue injuries of the knee. Several surgical reconstruction techniques are available, utilizing various tissues as a graft for the neo-ligament, including both autografts and allografts.

The "Over-the-top single-bundle technique with gracilis and semitendinosus tendons combined with lateral extra-articular tenodesis (LET)" was developed in 1998 by Prof. Marcacci and Prof. Zaffagnini, and it is still the preferred method for ACL reconstruction at the Second Clinic of the Rizzoli Orthopaedic Institute.

Cadaveric biomechanical studies have shown that combining LET with ACL reconstruction improves knee joint stability in both the anteroposterior and rotational planes. However, a recent in vivo study has challenged this hypothesis, showing that in patients undergoing surgery, the addition of LET enhances knee stability only in the anteroposterior direction and only for a limited period of six months. At twelve months postoperatively, joint laxity appeared similar to that of patients who did not undergo the additional procedure. Furthermore, the same study did not assess rotational instability using the pivot-shift test, an essential parameter as it is closely linked to knee stability and the patient's subjective perception of surgical success.

Despite the increasing use of LET in conjunction with ACL reconstruction, few studies have analyzed the short-term postoperative effects of lateral extra-articular tenodesis and its potential benefits during the early stages of rehabilitation and return to sport.

This study was conceived in response to this clinical question, with the goal of evaluating anteroposterior and rotational laxity in a group of patients who underwent ACL reconstruction combined with LET, in order to analyze clinical outcomes and, most importantly, any changes in stability during the early postoperative period.

The results aim to improve understanding of knee stability in the initial phase following surgery, providing valuable information for rehabilitation teams to optimize recovery protocols and more effectively guide return-to-sport decisions for patients undergoing both procedures.

03

Conditions studied

  • ACL Reconstruction
  • Tenodesis
  • ACL Injuries
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients will be recruited from those surgically treated at the Second Clinic of the Rizzoli Orthopaedic Institute, undergoing anterior cruciate ligament reconstruction using the "over-the-top" single-bundle technique with gracilis and semitendinosus tendons, combined with lateral extra-articular tenodesis (LET). Only patients with at least 6 months of follow-up after the surgery date will be enrolled. Subsequently, patients will be re-evaluated during a 12-month follow-up visit, as per standard clinical practice for this procedure.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients undergoing isolated ACL reconstruction using gracilis and semitendinosus tendons with the over-the-top technique and LET.
  • Both male and female patients.
  • Patients who have given consent to participate in the study.
  • Age between 18 and 50 years at the time of surgery.

Exclusion criteria

Exclusion Criteria:

  • Previous surgery on the same limb (meniscectomy, prior ACL reconstruction, displaced fractures).
  • Surgical technique different from Over-the-Top with LET using autologous gracilis and semitendinosus tendons.
  • Other concomitant ligament injuries requiring surgical treatment.
  • Patients undergoing additional procedures at the same time as ACL reconstruction and LET (e.g., concomitant osteotomy, meniscus transplant, cartilage procedure…).
  • Patients who did not provide .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
51 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. KYRA accelerometer

    KYRA is a non-invasive outpatient device that allows the assessment of dynamic laxity during the pivot shift phenomenon. The device enables highly precise quantification of the degree of laxity. The unit of measurement is millimeters per second squared.

    Time frame: 12 months

Secondary outcomes

  1. KT-1000 Arthrometer

    The KT-1000 is an objective assessment tool that measures anterior tibial translation relative to the position of the femur by applying a predefined force that pushes the tibia forward. It is commonly used in research settings to quantitatively evaluate static anteroposterior knee laxity following anterior cruciate ligament reconstruction surgeries.

    Time frame: 12 months

  2. Physical Examination

    A standard physical examination will be performed, including palpation, assessment of joint mobility, and laxity. During palpation, the typical tender points related to meniscal pathology are examined: the joint line areas on their anterior, middle, and posterior aspects. Pain is recorded as either present or absent. Joint mobility is assessed by asking the patient to flex and extend the knee, measuring the angle formed in degrees (0-130), with attention to the presence or absence of any joint clicks or catches. Laxity is evaluated using the classic tests: anterior drawer test, Lachman test, and pivot shift test.

    Time frame: 12 months

  3. Anterior Drawer Test

    This test allows evaluation of the anterior translation of the tibia relative to the femur with the knee flexed at 90 degrees. An increased translation suggests a lesion of the reconstructed ACL (neo-ACL). The degree of translation is quantified on a scale from 0 to 3.

    Time frame: 12 months

  4. Lachman Test

    This test allows evaluation of the anterior translation of the tibia relative to the femur with the knee flexed at 30 degrees. An increased translation suggests a lesion of the reconstructed ACL (neo-ACL). It is quantified on a scale from 0 to 3.

    Time frame: 12 months

  5. Pivot Shift Test

    This is a clinical maneuver used to assess rotational instability of the knee under examination. The test is performed by applying an internal rotation, valgus stress, and knee flexion; the occurrence of a tibial "clunk" or shift suggests a lesion of the reconstructed ACL (neo-ACL) associated with rotational instability. It is quantified on a scale from 0 to 3.

    Time frame: 12 months

  6. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a self-administered questionnaire used to evaluate both short- and long-term outcomes after a knee injury. It assesses five dimensions: pain, symptoms, activities of daily living, sports and recreational function, and knee-related quality of life. Each dimension is scored separately using a 5-point Likert scale ranging from 0 (no problems) to 4 (extreme problems). Scores for each dimension are summed and then transformed to a 0-100 scale, where 0 represents extreme knee problems and 100 indicates no knee problems. The KOOS meets essential standards for outcome measures and is useful for monitoring the progression of knee injuries and the effectiveness of treatments.

    Time frame: 12 months

  7. Lysholm Knee Score

    The Lysholm Knee Score is a validated measurement scale that evaluates knee function through 8 items, allowing assessment of the knee's condition in relation to the functional demands of daily activities. This assessment tool is used to evaluate surgical outcomes in patients operated on for ligament or meniscal injuries of the knee. The final score is obtained by summing the scores from the different items and ranges from 0 to 100. Scores are categorized into subgroups: Excellent (95-100), Good (84-94), Fair (65-83), and Poor (\<64).

    Time frame: 12 months

  8. VAS (Visual Analog Scale)

    The VAS is a unidimensional quantitative numerical scale for pain assessment ranging from 0 to 10. The patient selects the number that best describes the intensity of their pain at that moment. A score of 0 means no pain, and 10 indicates the worst possible pain.

    Time frame: 12 months

  9. Tegner Score

    The Tegner Score estimates a person's level of physical activity on a scale from 0 to 10, where 0 represents "disability" and 10 represents participation in competitive sports, such as national or international-level soccer. This score is the most widely used to define the physical activity level of patients with knee disorders. In the study, the Tegner Score will be completed directly by the examiner through an interview with the patient.

    Time frame: 12 months

  10. Complications or Subsequent Interventions

    Any complications and subsequent interventions will be documented and recorded in the Case Report Form (CRF). The staff responsible for distributing and collecting the questionnaires will assign an identification code on the questionnaire cover page to protect the privacy of the study participants.

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Jun 2028, 27 months after the start.

Of 73 non-industry observational studies under Anterior Cruciate Ligament Injuries, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 167. This study's planned 27 months is below that.

Counting every sponsor, half of 82 studies reached it within 37 months; a quarter within 13 and three quarters within 76.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 25, 2025
First posted
Jul 3, 2025
StartActual
Mar 24, 2026
Primary completionEst.
Jun 2028
CompletionEst.
Jun 2029
Last update
Apr 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07049484
Lead sponsor
Stefano Zaffagnini
Responsible party
Stefano Zaffagnini (Full Professor Medicine and Surgery, University of Bologna, Istituto Ortopedico Rizzoli) — Sponsor-investigator
First posted
Jul 3, 2025
Start date
Mar 24, 2026
Primary completion
Jun 2028 (estimated)
Completion
Jun 2029 (estimated)
Last update
Apr 22, 2026

Study contacts

stefano zaffagnini
Contact
stefano.zaffagnini@unibo.it
0516366075

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion